ClinicalTrials.gg
RecruitingNCT06623864IO/20240924Updated Oct 2, 2024

Significant Activities in the Integrated Person-centered Care Model

An interventional study of meaningful activities and other activities in Old Age; Dementia and Old Age; Debility, sponsored by Universidad de Burgos. Recruiting at 1 site in Spain. Open to male participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2024-10-02.

Sponsored by Universidad de Burgos · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 11 months ago, but the record still lists the study as recruiting.
  • Started Sep 2024; still recruiting 2 years 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Non-randomized
Ages
60 Years and older
Sex
Male
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 279 studies in Alzheimer Disease with a site in Spain — 54 open to participants now, 80 under way, 24 of them phase 3. Alzheimer Disease · Spain.

Planned enrollment
234th of 240
10 · median 258
Started
2024
with 19 others
No phase
66 of 279
17 open now
Primary completion
2024-12
later than 2 of 79 live
Registered
232nd of 279
by date

Among the 279 studies in Alzheimer Disease with a site in Spain, this one is the 234th largest by planned enrollment of the 240 interventional ones that give a count, is one of 20 that started in 2024, is one of 66 with no phase, reaches primary completion later than 2 of the 79 other live ones, and was the 232nd registered.

Alzheimer Disease

3,972 studies on the registry are indexed under Alzheimer Disease; 930 are open to participants now.

Browse Alzheimer Disease studies →

Open to participants now

54 of the 279 studies in Alzheimer Disease with a site in Spain are open now. Recruiting first, the newest first:

49 more — sign in →

All 54 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 645 Alzheimer Disease studies recruiting now, 282 (44%) set no upper age limit and 57 (9%) stop at 75 or younger; 34 take children under 18; 288 take healthy volunteers.

This study: 60 Years and older · male · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 279 studies in Alzheimer Disease with a site in Spain, or all of them as a file.
02

Study summary

The increasing life expectancy and global aging population necessitate changes in long-term gerontological services based on Person-Centred Care approaches. This study aims to improve Person-Centred Care in geriatric centers through meaningful activities and the role of occupational therapists and direct care professionals in developing these activities. A descriptive cross-sectional quasi-experimental design was proposed, with 10 participants.

Read the detailed description

Background: Increasing life expectancy means that the ageing of populations globally is on the rise. It is therefore important to promote changes in long-term gerontological services based on Person-Centred Care approaches, in which meaningful occupation serves as a basis and is supported by appropriate professional support, such as the occupational therapist and the direct care professional.

Objective: To improve Person-Centred Care in a geriatric centre, through the use of meaningful activities and to identify the role of the occupational therapist and direct care professional in the development of these activities.

Methods: A descriptive cross-sectional quasi-experimental pre-post single-group design is proposed. A total of 10 participants. The methodology used will be mixed. The data collection techniques and tools will be the PDC evaluation instrument pre and post intervention and a survey at the end of the project.

03

Conditions studied

  • Old Age; Dementia
  • Old Age; Debility
04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
Male
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • That the direct care worker has a degree as a nursing assistant, dependency care technician, geroculturist or certificate of professionalism.
  • The worker must speak and understand Spanish.
  • The residence must offer service during the day, in the morning or afternoon shift.
  • Workers must have been with the department for more than 4 months.

Exclusion criteria

Exclusion Criteria:

  • Workers who work night shift only.
  • Workers on rotating shifts in all departments of the residence.
  • Workers absent at the time of the study due to temporary leave, vacations or other causes.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Single group
Masking
Single (Care provider)
Enrollment
10 participants (estimated)

Study arms

  • Experimental
    single group

    The intervention proposal will be developed in a module with 10 elderly people, all of them men, with moderate dependence and older, with an average age of 84 years. All of them have multiple medical pathologies with the need for continuous nursing care.

    Other: meaningful activities

  • Experimental
    CONTROL GROUP

    The intervention proposal will be developed in a module with 10 elderly people, all of them men, with moderate dependence and older, with an average age of 84 years. All of them have multiple medical pathologies with the need for continuous nursing care.

    Other: other activities

Interventions

  • Othermeaningful activities

    The intervention proposal will be developed in a module with 27 elderly people, all of them men, with moderate dependence and older, with an average age of 84 years. All of them have multiple medical pathologies with the need for continuous nursing care.

  • Otherother activities

    The intervention proposal will be developed in a module with 27 elderly people, all of them men, with moderate dependence and older, with an average age of 84 years. All of them have multiple medical pathologies with the need for continuous nursing care.

06

What researchers measure

Primary outcomes

  1. Kruskal-Wallis test

    To compare the medians of the groups

    Time frame: 3 months

  2. Spearman's correlation coefficient

    This measure allows us to determine the strength and direction of the association between the variables

    Time frame: 3 months

07

Study locations

1 of 1 sites recruiting
  • Olalla Saiz Vazquez
    Burgos, 09003, Spain
    Recruiting
    • Olalla Saiz Vazquez · Contactosaiz@ubu.es · +34625685700
08

References and documents

Publications

  • McCormack, B., & McCance, T. (2017). Person-Centred Practice in Nursing and Health Care: Theory and Practice. Wiley-Blackwell.
  • World Health Organization. (2016). Framework on Integrated, People-Centred Health Services. WHO.
  • Gittell, J. H., & Vidal, M. (2018). Relational Coordination: Guidelines for Theory and Practice. Oxford University Press.
  • Edvardsson, D., & Innes, A. (2017). Measuring Person-Centred Care: A Review of Tools and Methodologies. Journal of Nursing Scholarship, 49(2), 223-235. https://doi.org/10.1111/jnu.12276
  • Dewing, J. (2008). Person-Centred Dementia Care: A Vision to Be Realised. Journal of Nursing Management, 16(3), 261-268. https://doi.org/10.1111/j.1365-2834.2007.00848.x

Individual participant data

Plan to share: No — Although each participant will provide their name and email address to register for the study, their data and survey results will be completely anonymous and linked to a participant code. On each measurement occasion, participants will be emailed a link to the survey and, when clicked, will be taken to the google-forms web platform that will host the surveys. The web surveys will not ask for any information that can be used to identify a specific participant, and google-forms will not record any metadata.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2024 (actual). Primary completion is estimated for Dec 2024, 2 months after the start.

Of 887 non-industry interventional studies with no phase under Alzheimer Disease, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 51. This study's planned 2 months is below that.

Counting every sponsor, half of 964 studies reached it within 29 months; a quarter within 15 and three quarters within 51.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 24, 2024
First posted
Oct 2, 2024
StartActual
Sep 24, 2024
Primary completionEst.
Dec 20, 2024
CompletionEst.
Jan 20, 2025
Last update
Oct 2, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 2, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06623864
Lead sponsor
Universidad de Burgos
Responsible party
Sponsor
First posted
Oct 2, 2024
Start date
Sep 24, 2024
Primary completion
Dec 20, 2024 (estimated)
Completion
Jan 20, 2025 (estimated)
Last update
Oct 2, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion